Cargando…

Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery

BACKGROUND: Major societal guidelines recommend a 5-day stop interval before cardiac surgery for patients with acute coronary syndrome receiving clopidogrel. Yet, many such patients present with high acuity, generating surgeon inclination toward use of shorter stop intervals. Thus, this study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Bright, Hirsch, Gregory M., Doucette, Steve, Herman, Christine R., Gainer, Ryan, Mokhtar, Ahmed T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767124/ https://www.ncbi.nlm.nih.gov/pubmed/35072023 http://dx.doi.org/10.1016/j.cjco.2021.08.006

Ejemplares similares

The Risk of Bleeding and Adverse Events with Clopidogrel in Elective Hip and Knee Arthroplasty Patients
por: Wu, Cheng-Ta, et al.
Publicado: (2022)

Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
por: Tamura, Takao, et al.
Publicado: (2012)

Thoracentesis under clopidogrel is not associated with excessive bleeding events: a cohort study
por: Perl, Sivan, et al.
Publicado: (2020)

To Stop Bleeding
Publicado: (1882)

To Stop Bleeding
Publicado: (1880)

New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
por: Liu, Xiaomin, et al.
Publicado: (2021)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

The STOP the Bleeding Campaign
por: Rossaint, Rolf, et al.
Publicado: (2013)

To Stop Nose-Bleeding
Publicado: (1898)

Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2018)

Response to mass casualty events: from the battlefield to the Stop the Bleed campaign
por: Knudson, M Margaret, et al.
Publicado: (2016)

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2019)

331 A Machine Learning-based Pharmacogenomic Association Study of Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic Patients on Clopidogrel
por: Arroyo, Luis A. Rosario, et al.
Publicado: (2022)

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice
por: Mullen, Liam, et al.
Publicado: (2021)

Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020)

4423 Impact of Gender on High On-Treatment Platelet Reactivity (HPR) and Major Adverse Cardiovascular Events (MACEs) in Caribbean Hispanic patients using Clopidogrel
por: Nunez Medina, Hector Jose, et al.
Publicado: (2020)

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study
por: Storey, Robert F., et al.
Publicado: (2014)

The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention
por: Zhang, Zhaowei, et al.
Publicado: (2020)

Small bowel ulcer bleeding due to suspected clopidogrel use in a patient with clopidogrel resistance: A case report
por: Lee, Sang Hoon, et al.
Publicado: (2021)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Modified STOP-Bang for predicting perioperative adverse events in the Thai population
por: Sangkum, Lisa, et al.
Publicado: (2021)

Heparin: Major bleeding event: case report
Publicado: (2021)

The Efficacy and Adverse Reaction of Bleeding of Clopidogrel plus Aspirin as Compared to Aspirin Alone after Stroke or TIA: A Systematic Review
por: Huang, Yan, et al.
Publicado: (2013)

Do Clopidogrel Nonresponders Have an Increased Risk of Adverse Events during Supra-Aortal Angioplasty and Stenting?
por: Koerner, Heiko, et al.
Publicado: (2012)

Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis
por: Cardoso, Rhanderson N, et al.
Publicado: (2015)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)

Aspirin/clopidogrel/ticagrelor: Diffuse ooze and bleeding: 2 case reports
Publicado: (2021)

Thrombocytopenia Induced by Clopidogrel: A Rare Adverse Effect
por: Távora, Catarina, et al.
Publicado: (2023)

Proton Pump Inhibitor and Clopidogrel Use After Percutaneous Coronary Intervention and Risk of Major Cardiovascular Events
por: Maret-Ouda, John, et al.
Publicado: (2021)

Learners’ perspectives on Stop the Bleed: a course to improve survival during mass casualty events
por: Zhao, Karen L, et al.
Publicado: (2019)

Cytochrome P450 2C19 Polymorphisms and Its Association With Major Adverse Cardiac Events in Post-coronary Intervention Patients on Clopidogrel in the Tertiary Care Center
por: Kambhampati, Nikhil Teja, et al.
Publicado: (2023)

Risk Factors for Bleeding and Clinical Ineffectiveness Associated With Clopidogrel Therapy: A Comprehensive Meta‐Analysis
por: Nguyen, Khoa A., et al.
Publicado: (2020)

Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study
por: Hsieh, Ming-Shun, et al.
Publicado: (2020)

Pharmacological adjuncts to stop bleeding: options and effectiveness
por: Panteli, M., et al.
Publicado: (2015)

Xerosis and pruritus as major EGFRI-associated adverse events
por: Clabbers, Julia M. K., et al.
Publicado: (2015)

Postoperative Bleeding Risk for Oral Surgery under Continued Clopidogrel Antiplatelet Therapy
por: Gröbe, Alexander, et al.
Publicado: (2015)

Impact of Clopidogrel Loading for Coronarography on Bleeding After Urgent First Time CABG
por: Hoxha, Aleksander, et al.
Publicado: (2018)

The Association Between Clopidogrel and Gastrointestinal Bleeding After Primary Total Joint Arthroplasty
por: Kugelman, David, et al.
Publicado: (2021)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vhkfl3hbmoaoj5ir1f9ak83km7